Scientists Inch Closer to Alzheimer’s Blood Test

Thursday, 02 May 2013 04:10 PM

By Nick Tate

  Comment  |
   Contact  |
  Print   |
    A   A  
  Copy Shortlink
Australian researchers are reporting an advance that brings scientists one step closer to developing a blood test for the early detection of Alzheimer's disease.
The investigators have identified blood-based biological markers that are associated with the buildup of a toxic protein in the brain that occurs years before symptoms of Alzheimer’s appear and irreversible brain damage has occurred.
"Early detection is critical if we are to make any real difference in the battle against Alzheimer's, giving those at risk a much better chance of receiving treatment earlier, before it's too late to do much about it," said Samantha Burnham, M.D., a researcher with Australia's national science agency, the Commonwealth Scientific and Industrial Research Organisation.

ALERT: 5 Signs You’ll Get Alzheimer’s Disease
To identify the biomarkers, the team used sophisticated mathematical models to analyze data from 273 participants in an ongoing study of aging and health. The work identified nine markers that correlate with brain imaging scans measuring a toxic protein, amyloid beta, that deposits in the brain as plaques early in Alzheimer’s development.
"The progressive buildup of the toxic protein, amyloid beta, is one of the earliest changes in the brain associated with the development of Alzheimer's disease," said Noel Faux, M.D., from the Florey Institute for Neuroscience and Mental Health.
"A recent study from the [aging study] team showed that amyloid beta levels become abnormal about 17 years before dementia symptoms appear. This gives us a much longer time to intervene to try to slow disease progression if we are able to detect cases early."
Dr. Burnham said the new study points the way to developing a new “low cost, minimally invasive population based screening test for Alzheimer's."
She added: "A blood test would be the ideal first stage to help identify many more people at risk before a diagnosis is confirmed with cognitive tests and [brain] imaging or cerebral spinal fluid (CSF) testing."
The study was published in the journal Molecular Psychiatry.

© 2014 NewsmaxHealth. All rights reserved.

  Comment  |
   Contact  |
  Print   |
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
Zip Code:
Privacy: We never share your email.
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Flu Tightens Grip on South, Midwest

Thursday, 18 Dec 2014 16:06 PM

The flu is starting to tighten its grip on much of the United States,particularly in the South and Midwest, U.S. health  . . .

Advil Found to Reduce Skin Cancer Risk

Thursday, 18 Dec 2014 16:00 PM

Common painkillers, including ibuprofen, might slightly reduce your risk of developing a form of skin cancer, researcher . . .

Genes Affect Gut Bacteria That Cause IBD

Thursday, 18 Dec 2014 15:53 PM

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, runs in families and now researchers . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

America's News Page
©  Newsmax Media, Inc.
All Rights Reserved